The effect of ferric citrate on IV iron, ESA utilization and laboratory parameters in real-world dialysis practice

Trial Profile

The effect of ferric citrate on IV iron, ESA utilization and laboratory parameters in real-world dialysis practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2017

At a glance

  • Drugs Ferric citrate (Primary)
  • Indications Hyperphosphataemia; Iron deficiency anaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Nov 2017 New trial record
    • 04 Nov 2017 According to a Keryx Biopharmaceuticals media release, data from this study were presented at the American Society of Nephrologys (ASN) 2017 Kidney Week.
    • 04 Nov 2017 Results presented in a Keryx Biopharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top